Skip to content
Veridian Research

Research Insights

Peptide guides, regulatory developments, and analysis of the published literature, written for people sourcing reference materials for laboratory work.

Most writing about research peptides is either a product page in disguise or a summary of a summary. We write from the primary literature and cite it, so you can check the claim rather than take our word for it. Where the evidence is thin or preclinical only, we say that plainly instead of rounding it up.

For structured, per-compound reference material covering mechanism of action, molecular specifications and published study summaries, see the research peptide encyclopedia, or the side-by-side comparisons if you are deciding between two compounds. Every certificate of analysis we receive is published in the certificate library.

What FDA's 2026 peptide warning letters cite, sentence by sentence
regulatoryfda
Read Article

What FDA's 2026 peptide warning letters cite, sentence by sentence

Twelve warning letters to research-framed peptide sellers in 2026, read from the primary text. The same footnote disposes of the disclaimer in every one, the solvent is charged as a drug, a calculator is called evidence, and renamed products are listed next to what they are.

VR
Veridian ResearchSep 6, 2026
3 min read
regulatoryfda
Read Article

What FDA cited in the August 2026 peptide warning letters

FDA posted four warning letters to online peptide sellers on 1 September 2026. In each one the evidence was the seller's own website copy, and in each one the agency held that a research-use-only disclaimer did not displace it.

VR
Veridian ResearchSep 6, 2026
3 min read
regulatorystate law
Read Article

What Louisiana's new peptide law does and does not do

Louisiana Act 374 took effect on 1 August 2026. It restricts what state licensing boards may prohibit. It does not change federal law, and it does not change anything for laboratory research supply.

VR
Veridian ResearchSep 6, 2026
3 min read
regulatoryfda
Read Article

What FDA's 1 September peptide warning letters cite

FDA posted four warning letters to peptide sellers on 1 September 2026, all issued 24 August. The evidentiary theory is the notable part - the solvent sold with the peptides and the sellers' calculators cited as evidence of human-use intent, and research-framed product copy read as drug labelling.

VR
Veridian ResearchSep 6, 2026
3 min read
literature analysisevidence base
Read Article

How much human trial data exists for research peptides

Counted across eighteen compounds in the same PubMed query on the same day, the indexed controlled-trial literature ranges from 141 records to zero. The spread is the finding, and it does not track how often a compound is discussed.

VR
Veridian ResearchSep 6, 2026
3 min read
mass spectrometryidentity
Read Article

How a peptide's identity is confirmed, and what HPLC misses

Chromatography establishes that one species dominates a sample. It does not establish which species that is. Identity is a mass measurement — and even a matching mass leaves specific classes of error undetected.

VR
Veridian ResearchSep 6, 2026
3 min read
regulatorystandards
Read Article

What research grade and pharmaceutical grade actually mean

Neither phrase is defined anywhere in FDA's regulations. A search of the Code of Federal Regulations finds both terms only in EPA rules, never in Title 21. What the law does define is monograph conformance, and that is a different kind of claim.

VR
Veridian ResearchSep 6, 2026
3 min read
purityhplc
Read Article

What a 99% purity figure does not tell you

An HPLC purity figure is an area ratio measured on one aliquot, at one wavelength, on one date. It establishes chromatographic homogeneity — not mass, not identity, and not the condition of the material afterwards.

VR
Veridian ResearchSep 6, 2026
3 min read
endotoxincertificate of analysis
Read Article

Why endotoxin is not on a peptide purity certificate

Endotoxin is a separate assay run on a separate sample, and a chromatographic purity figure carries no information about it. The concentrations that alter a cell culture readout sit far below anything HPLC can resolve.

VR
Veridian ResearchSep 6, 2026
3 min read
preclinicalreproducibility
Read Article

Why preclinical peptide results often fail to replicate

Discordance between animal experiments and human trials has been measured directly, and the causes separate into three: the model, the way the experiment was run and reported, and the material it was run on.

VR
Veridian ResearchSep 6, 2026
3 min read
endotoxinlal
Read Article

What an endotoxin test measures, and what it misses

Endotoxin testing detects bacterial lipopolysaccharide by biological reactivity, not by chromatography. A high HPLC purity figure carries no information about it, and the assay itself can be defeated by the sample matrix.

VR
Veridian ResearchSep 6, 2026
3 min read
cell culturein vitro methods
Read Article

What happens to a peptide added to cell culture medium

Three processes start immediately — adsorption to the vessel, proteolysis by serum and cell-secreted enzymes, and chemical modification in buffer. The concentration a monolayer actually sees is therefore lower than the nominal figure, by an amount that is rarely measured.

VR
Veridian ResearchSep 6, 2026
3 min read
lyophilisationstability
Read Article

Why research peptides ship as lyophilised powder

Freeze-drying removes the water that drives most peptide degradation, but a dry solid is not an inert one. What the formulation literature establishes about lyophilisation, residual moisture and cold chain — and what it does not.

VR
Veridian ResearchSep 6, 2026
3 min read
mass spectrometryhplc
Read Article

What mass spectrometry confirms that HPLC cannot

Chromatography establishes that one species dominates a sample. Mass spectrometry establishes what that species weighs. Neither, on its own, establishes sequence — and several of the modifications that matter most are invisible to mass alone.

VR
Veridian ResearchSep 6, 2026
3 min read
regulatoryfda
Read Article

What research use only actually means in US law

The phrase has a specific home in FDA's regulations, and it is a labelling condition attached to in vitro diagnostic products. It is not a general exemption, and it does not determine whether an article is a drug. That turns on intended use, which FDA reads from objective evidence including a seller's own website.

VR
Veridian ResearchSep 6, 2026
3 min read
regulatoryfda
Read Article

Where FDA's peptide compounding dockets stand after July 2026

Two FDA compounding dockets moved in July 2026 and neither produced a final decision. What is actually on the record, with Federal Register citations, and what remains open.

VR
Veridian ResearchAug 1, 2026
3 min read
Peptides Are Becoming the Norm: What the FDA Shift Means for Research
peptidesFDA
Read Article

Peptides Are Becoming the Norm: What the FDA Shift Means for Research

The FDA is poised to reclassify approximately 14 peptides for compounding pharmacy use, marking a turning point for peptide research accessibility in the United States.

VR
Veridian ResearchApr 5, 2026
3 min read